These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30115749)

  • 1. Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model.
    Torgeman A; Schwartz A; Diamant E; Baruchi T; Dor E; Ben David A; Pass A; Barnea A; Tal A; Rosner A; Rosen O; Zichel R
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.
    Diamant E; Pass A; Rosen O; Ben David A; Torgeman A; Barnea A; Tal A; Rosner A; Zichel R
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Running Wheel Mouse Model for Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.
    Schwartz A; Ben David A; Hotoveli M; Dor E; Diamant E; Vivyorka A; Rosen O; Torgeman A; Zichel R
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0042121. PubMed ID: 33972251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of Botulism.
    Torgeman A; Diamant E; Dor E; Schwartz A; Baruchi T; Ben David A; Zichel R
    Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
    Shi DY; Lu JS; Mao YY; Liu FJ; Wang R; Du P; Yu S; Yu YZ; Yang ZX
    Appl Microbiol Biotechnol; 2023 May; 107(10):3205-3216. PubMed ID: 37058230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic treatment of botulism with a clinically approved small molecule.
    Vazquez-Cintron E; Machamer J; Ondeck C; Pagarigan K; Winner B; Bodner P; Kelly K; Pennington MR; McNutt P
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31996484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model.
    Snow DM; Cobb RR; Martinez J; Finger-Baker I; Collins L; Terpening S; Syar ES; Niemuth N; Kobs D; Barnewall R; Farr-Jones S; Marks JD; Tomic MT
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models.
    You Z; Yang H; Xin W; Kang L; Gao S; Wang J; Zhang T; Wang J
    Hum Vaccin Immunother; 2014; 10(8):2321-7. PubMed ID: 25424938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.
    Dembek ZF; Smith LA; Rusnak JM
    Disaster Med Public Health Prep; 2007 Nov; 1(2):122-34. PubMed ID: 18388640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
    Barash JR; Arnon SS
    J Infect Dis; 2014 Jan; 209(2):183-91. PubMed ID: 24106296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
    J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.
    Gonul Oner O; Gudek HC; Erturk Cetin O; Demir S
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):82-84. PubMed ID: 36728838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins.
    Diamant E; Torgeman A; Epstein E; Mechaly A; David AB; Levin L; Schwartz A; Dor E; Girshengorn M; Barnea A; Mazor O; Zichel R
    ALTEX; 2022; 39(1):113-122. PubMed ID: 34798660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E.
    Ben David A; Barnea A; Diamant E; Dor E; Schwartz A; Torgeman A; Zichel R
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
    Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
    PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
    Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW
    Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature.
    Eser F; Hasanoğlu İ; Kayaaslan B; Kaya Kalem A; Bilen Ş; Orhan G; Güner R
    J Infect Dev Ctries; 2024 Mar; 18(3):480-487. PubMed ID: 38635607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.